Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ospemifene on Brain Activation in Women with FSIAD
NCT04677491Phase 4Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Nov 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ospemifene in Vulvovaginal atrophy (VVA), female sexual interest/arousal disorder (FSIAD), sponsored by Hospital Clínic de Barcelona. Started Nov 2021; status: completed.
02
Drugs
ospemifene
03
Conditions
Vulvovaginal atrophy (VVA)female sexual interest/arousal disorder (FSIAD)
Beyond the preview
Go deeper on NCT04677491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04677491.